Mark E. Johnson

2.1k total citations
32 papers, 1.8k citations indexed

About

Mark E. Johnson is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark E. Johnson has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark E. Johnson's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Bone Tumor Diagnosis and Treatments (5 papers). Mark E. Johnson is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Bone Tumor Diagnosis and Treatments (5 papers). Mark E. Johnson collaborates with scholars based in United States, Spain and Germany. Mark E. Johnson's co-authors include Daniel Blankschtein, Sjoerd H. van der Burg, Grayson B. Lipford, Rienk Offringa, Jan Nouta, Cornelis J.M. Melief, Samir Mitragotri, Zhibin Guan, Anand Iyer and George Koukoulis and has published in prestigious journals such as Nature Biotechnology, The Journal of Immunology and Biomaterials.

In The Last Decade

Mark E. Johnson

31 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Johnson United States 20 693 395 365 263 256 32 1.8k
François Fay United States 21 569 0.8× 311 0.8× 362 1.0× 156 0.6× 119 0.5× 39 1.7k
Takashi Mori Japan 31 1.0k 1.5× 187 0.5× 263 0.7× 624 2.4× 370 1.4× 146 2.8k
Jooho Park South Korea 26 920 1.3× 148 0.4× 266 0.7× 199 0.8× 404 1.6× 73 2.1k
Stefan Nagel Germany 31 1.3k 1.9× 198 0.5× 655 1.8× 110 0.4× 721 2.8× 125 2.9k
Vinu Krishnan United States 20 576 0.8× 290 0.7× 193 0.5× 112 0.4× 153 0.6× 27 1.6k
Kim E. Creek United States 28 1.1k 1.5× 63 0.2× 185 0.5× 102 0.4× 419 1.6× 87 2.1k
Shuang Cai China 23 815 1.2× 177 0.4× 201 0.6× 248 0.9× 309 1.2× 60 1.8k
Ninh M. La‐Beck United States 19 603 0.9× 73 0.2× 349 1.0× 177 0.7× 504 2.0× 43 1.8k
Güneş Esendağlı Türkiye 27 569 0.8× 238 0.6× 628 1.7× 104 0.4× 551 2.2× 94 2.0k

Countries citing papers authored by Mark E. Johnson

Since Specialization
Citations

This map shows the geographic impact of Mark E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Johnson more than expected).

Fields of papers citing papers by Mark E. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Johnson. The network helps show where Mark E. Johnson may publish in the future.

Co-authorship network of co-authors of Mark E. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Johnson. A scholar is included among the top collaborators of Mark E. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Johnson. Mark E. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Mark E., Yang Cao, Lin Zhang, et al.. (2018). Dendritic peptide bolaamphiphiles for siRNA delivery to primary adipocytes. Biomaterials. 178. 458–466. 27 indexed citations
2.
Zeng, Hanxiang, et al.. (2015). Multivalent dendritic polyglycerolamine with arginine and histidine end groups for efficient siRNA transfection. Beilstein Journal of Organic Chemistry. 11. 763–772. 9 indexed citations
3.
Zeng, Hanxiang, Mark E. Johnson, Nathan J. Oldenhuis, Timothy N. Tiambeng, & Zhibin Guan. (2015). Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA Delivery. ACS Central Science. 1(6). 303–312. 58 indexed citations
4.
Johnson, Mark E.. (2008). Development translates discoveries into products. Nature Biotechnology. 26(12). 1385–1386.
5.
Sáenz, A., et al.. (2006). Effect of Surfactant Protein A on the Physical Properties and Surface Activity of KL4-Surfactant. Biophysical Journal. 92(2). 482–492. 27 indexed citations
6.
Sáenz, A., Olga Cañadas, Luís A. Bagatolli, Mark E. Johnson, & Cristina Casals. (2006). Physical properties and surface activity of surfactant‐like membranes containing the cationic and hydrophobic peptide KL4. FEBS Journal. 273(11). 2515–2527. 40 indexed citations
7.
Man, Tsz‐Kwong, Murali Chintagumpala, Jaya Visvanathan, et al.. (2005). Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy. Cancer Research. 65(18). 8142–8150. 107 indexed citations
8.
Lau, Ching C., Charles P. Harris, Xinyan Lu, et al.. (2003). Frequent amplification and rearrangement of chromosomal bands 6p12‐p21 and 17p11.2 in osteosarcoma. Genes Chromosomes and Cancer. 39(1). 11–21. 118 indexed citations
9.
Trask, Douglas K., Gregory T. Wolf, Carol R. Bradford, et al.. (2002). Expression of Bcl‐2 Family Proteins in Advanced Laryngeal Squamous Cell Carcinoma: Correlation With Response to Chemotherapy and Organ Preservation. The Laryngoscope. 112(4). 638–644. 89 indexed citations
10.
Ostrowski, Mary L., et al.. (2000). Low-Grade Intraosseous Osteosarcoma With Prominent Lymphoid Infiltrate. Archives of Pathology & Laboratory Medicine. 124(6). 868–871. 5 indexed citations
11.
Mitragotri, Samir, Mark E. Johnson, Daniel Blankschtein, & Róbert Langer. (1999). An Analysis of the Size Selectivity of Solute Partitioning, Diffusion, and Permeation across Lipid Bilayers. Biophysical Journal. 77(3). 1268–1283. 72 indexed citations
12.
Truong, Luan D., Frank E. Smith, Mary L. Ostrowski, et al.. (1999). Malignant chondroblastoma presenting as a recurrent pelvic tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy. Skeletal Radiology. 28(11). 644–650. 20 indexed citations
13.
Oshiro, Yumi, Vijaya Chaturvedi, Tipu Nazeer, et al.. (1998). Altered p53 is associated with aggressive behavior of chondrosarcoma. Cancer. 83(11). 2324–2334. 44 indexed citations
14.
Johnson, Mark E., et al.. (1997). Evaluation of Solute Permeation through the Stratum Corneum: Lateral Bilayer Diffusion as the Primary Transport Mechanism. Journal of Pharmaceutical Sciences. 86(10). 1162–1172. 250 indexed citations
15.
Johnson, Mark E., Samir Mitragotri, Ashish Patel, Daniel Blankschtein, & Robert Langer. (1996). Synergistic Effects of Chemical Enhancers and Therapeutic Ultrasound on Transdermal Drug Delivery. Journal of Pharmaceutical Sciences. 85(7). 670–679. 98 indexed citations
16.
Johnson, Mark E., et al.. (1995). Evidence for Autocrine Basis of Transformation in NIH-3T3 Cells Transfected with met/HGF Receptor Gene. Growth Factors. 12(4). 303–313. 5 indexed citations
17.
Johnson, Mark E., et al.. (1995). Permeation of Steroids through Human Skin. Journal of Pharmaceutical Sciences. 84(9). 1144–1146. 82 indexed citations
18.
Johnson, Mark E., et al.. (1995). Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection. Cancer Letters. 96(1). 37–48. 19 indexed citations
19.
Simpkins, Cuthbert, et al.. (1990). Prostanglandin D2 modulates human neutrophil intracellular calcium flux and inhibits superoxide release via its ring carbonyl. Life Sciences. 46(11). 793–801. 8 indexed citations
20.
Simpkins, Cuthbert, et al.. (1985). Naloxone inhibits superoxide release from human neutrophils. Life Sciences. 37(15). 1381–1386. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Fay Breakdown of academic impact, for papers by Takashi Mori Breakdown of academic impact, for papers by Jooho Park Breakdown of academic impact, for papers by Stefan Nagel Breakdown of academic impact, for papers by Vinu Krishnan Breakdown of academic impact, for papers by Kim E. Creek Breakdown of academic impact, for papers by Shuang Cai Breakdown of academic impact, for papers by Ninh M. La‐Beck Breakdown of academic impact, for papers by Güneş Esendağlı
Rankless by CCL
2026